Overview

Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This prospective study compares an oral direct factor Xa inhibitor with LMWH for thromboprophylaxis in the patients undergoing THA.
Phase:
Phase 4
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Enoxaparin
Rivaroxaban